Novartis AG is 65.1x more valuable than Travere Therapeutics, Inc. by market capitalization ($283.13 B vs $4.35 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TVTX | NVS |
|---|---|---|
| Market cap | $4.35 B | $283.13 B |
| US-listed rank | #1502 | #47 |
| Revenue (latest FY) | $490.73M | - |
| Net income (latest FY) | -$25.55M | - |
| Net margin | -5.2% | - |
| SEC filings | 1,240 | 947 |
Novartis AG is 65.1x more valuable than Travere Therapeutics, Inc. by market capitalization ($283.13 B vs $4.35 B).
Full pages: Travere Therapeutics, Inc. and Novartis AG, or browse the full rankings.